Americans fortunate enough to receive vaccines right now, outside of clinical trials, are getting ones made by either Pfizer or Moderna. But newly released data from Novavax and Johnson & Johnson suggests that more vaccines could be on the way. Dan digs into the news and why it matters, especially as COVID-19 variants begin to spread, with Tom Frieden, forme ... Show More
Dec 2021
The year psychedelics went mainstream
Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022. Alison Snyder, managing editor and author of Axios Science, joins Axios Re:Cap senior producer Naomi Shavin to discuss a major ... Show More
11m 21s
Nov 2020
Moderna's chief medical officer on its blockbuster vaccine news
Moderna Therapeutics today reported a 94.5% efficacy for its COVID-19 vaccine, which needn't be stored at the same ultra-cold temperatures as does a similar vaccine developed by Pfizer. It also said short-term safety concerns, such as headaches and injection site soreness, self-r ... Show More
17m 46s
Dec 2021
Is Pfizer's antiviral pill the game changer we've been waiting for? Plus, is it still accurate to call this a pandemic of the unvaccinated?
Promising data from Pfizer shows its antiviral Covid-19 pill reduces severe illness, hospitalizations, and death. And it appears to hold up against the Omicron variant.A healthcare professional who is fully vaccinated and boosted just came down with Covid-19 for a second time.Cal ... Show More
24m 20s